amcure amcure.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

amcure is a spin-off from the Karlsruhe Institute of Technology established in 2012. The company develops peptide active ingredients for the treatment of highly metastatic carcinomas. The first of their development candidates have entered advanced preclinical trials. Relevant proof- of-concept studies indicate a unique effectiveness regarding different types of tumors, especially pancreatic cancer.

amcure is a spin-off from the Karlsruhe Institute of Technology established in 2012. The company develops peptide active ingredients for the treatment of highly metastatic carcinomas. The first of their development candidates have entered advanced pr...Show all

Company (Alive / Active)

Phone: +49 7247 934249-0

Fax:

Hermann-von Helmholtz-Platz 1

Eggenstein-Leopoldshafen, D-76344
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
amcure $15.2M Aug 31, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related amcure Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cd44v6-derived peptides for treating metastasizing cancer Nov 21, 2013 Mar 14, 2017 Patent
Cd44v6-derived peptides for treating pancreatic cancer Nov 21, 2013 Mar 07, 2017 Patent
Cd44v6-derived peptides for treating breast cancer Nov 21, 2013 Mar 07, 2017 Patent
Cd44v6-derived peptides for treating metastasizing cancer Jan 25, 2017 Application
Cd44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases Dec 07, 2015 Application